News

In the fog of jurisdictional war, the legal battle between Donald Trump & Gavin Newsom over troops on the ground the streets ...
Fred Kocher sits down with Lilly Wellington, Executive Director of the New Hampshire Commission On Aging, and Jennifer ...
The combination of once-weekly cagrilintide 2.4 mg and semaglutide 2.4 mg conferred greater weight loss at 68 weeks compared with placebo in patients with overweight or obesity with or without ...
Wall Street’s major market averages seesawed back and forth on Friday and finished mixed as Federal Reserve Governor ...
The U.S. Department of Agriculture considers vaccinating poultry against bird flu amidst a major animal-health crisis, with ...
Novo Nordisk’s next-gen weight loss drug and Zepbound “seem fairly equal to me,” one expert says after release of new ...
When an impressive opening act at the professional level and strong performances at the U23 camp string together, a first ...
CHICAGO -- An investigational, oral small-molecule GLP-1 receptor agonist improved glycated hemoglobin levels in adults with ...
A protocol designed for primary care increased weight loss across a quarter of a million people, but only 25% of those with a ...
An obesity drug from China helped patients lose a lot of weight in a late-stage clinical trial, making it a prospective new ...
The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS ...
An intervention designed to emphasize management of overweight and obesity in primary care settings was associated with ...